State ordering guide
Sourcing Exosomes in Georgia
Licensed Georgia practices order Kimera exosome material from ExaVeyra as research-grade product, shipped cold-chain from Miami Beach with a Certificate of Analysis and lot traceability on every vial. Georgia buyers need their own professional license and NPI; the wholesale distributor license is the supplier’s obligation, not the purchaser’s.
Georgia enacted a stem cell statute in May 2026 that is unusual in one respect: it lets a physician assistant or nurse practitioner perform qualifying stem cell therapy under a lawful designation from a physician, which no other state authorises. It is worth knowing what that statute covers, and what it does not.
At a glance
| Question | Answer |
|---|---|
| Does ExaVeyra ship to Georgia? | Yes. Cold-chain from Miami Beach, as we do to all 50 states |
| Cold-chain transit from Miami | 1 to 3 business days |
| State regenerative-medicine statute | HB 1275 (2026) |
| Does that statute reach exosomes? | No. Its definition is written around cells; exosomes are acellular and governed federally |
| Physician delegation required to hand off medical acts | Yes |
| Who holds the wholesale distribution permit | The supplier, not the purchasing practice |
| What ExaVeyra supplies here | Kimera exosome material and 503A compounded preparations |
| Last reviewed | 9 August 2026 |
Ordering from Georgia
ExaVeyra ships to licensed practices in all 50 states, Georgia included. Distribution-side licensing is handled by us, so your practice orders against its own professional license and NPI. What varies state to state is not whether product can reach you, but the indications it may be used for under federal law and how Georgia regulates who performs the procedure.
What your practice provides
- An active Georgia professional license in good standing, verifiable through the Georgia Composite Medical Board or the Georgia Board of Nursing.
- A valid NPI, which ExaVeyra verifies at account setup.
- A signed research-use acknowledgment on file for exosome material.
- A Georgia sales and use tax certificate of exemption if the practice is purchasing for resale rather than for use in its own operations.
How the state permits wholesale distribution
Georgia licenses wholesale distributors through the Board of Pharmacy, with personal certification forms processed by the Georgia Drugs and Narcotics Agency, and issues out-of-state wholesale permits for distributors shipping in. Georgia carves out two exceptions other states generally do not: an out-of-state firm making intracompany transfers of drugs or devices to a commonly owned licensed Georgia firm does not need a separate license, and an out-of-state third-party logistics provider licensed by its home state or by the FDA is likewise exempt. The license sits with the distributor, not with the purchasing practice.
O.C.G.A. §§ 26-4-113, 26-4-115; Ga. Comp. R. & Regs. 480-7-.02 · Georgia Board of Pharmacy and Georgia Drugs and Narcotics Agency
Georgia regenerative-medicine law
Georgia enacted HB 1275, codified at O.C.G.A. tit. 43 ch. 34 art. 2, effective 11 May 2026.
Physicians, and physician assistants or nurse practitioners acting under a lawful designation from a physician, performing qualifying human stem cell therapy within their scope of practice. Human stem cells must be retrieved, manufactured, and stored in a facility registered with the FDA or certified by an accepted accreditor such as the World Marrow Donor Association, wherever located. Advertising must carry language stating the therapy is not FDA approved and encouraging patients to consult their primary care provider. Notably, Georgia does not confine the therapy to orthopedics, wound care, and pain management the way Florida does.
- Not limited to specific conditions
- Designation of a PA or nurse practitioner by a physician
- FDA-registered or accredited source facility
- Advertising notice and patient consent
- Excludes stem cells derived from aborted fetuses
How this applies to exosomes
Georgia HB 1275 is a stem cell statute. Its subject is human stem cells and their retrieval, manufacture, and storage, and its notable feature is who may administer the therapy rather than what the therapy consists of. Exosomes are acellular extracellular vesicles rather than stem cells, so the statute does not reach them either to permit or to restrict. This is where Georgia and Tennessee diverge despite enacting statutes eight days apart: Tennessee widened the subject and named exosome-based regenerative products expressly, while Georgia widened who may operate. Exosome products in Georgia remain governed by federal law, under which no exosome product has been approved by the FDA for administration to humans. ExaVeyra supplies Kimera material for topical aesthetic use in clinics and for research applications, with full COA and lot documentation.
Who can handle product in a Georgia practice
Georgia is a filing state, which is the practical thing to plan around. Nurse protocol agreements and physician assistant arrangements are filed with the Georgia Composite Medical Board before anyone begins practicing under them, and nurse protocol agreements are reviewed at least annually. Compliance also touches more agencies than most states, including the Composite Medical Board, the Georgia Board of Nursing, and the Georgia Drugs and Narcotics Agency.
| Role | Scope under state law |
|---|---|
| MD / DO | Physicians licensed by the Georgia Composite Medical Board may perform medical acts within their scope and are the source of any delegation. Under HB 1275 a physician may also lawfully designate a physician assistant or nurse practitioner to perform qualifying stem cell therapy. |
| NP / APRN | Nurse practitioners practice under a written Nurse Protocol Agreement with a delegating physician. The agreement defines scope, prescriptive limits, chart review frequency, and communication procedures, is filed with the Georgia Composite Medical Board, and is reviewed at least annually. |
| PA | Physician assistants practice under a job description or agreement approved by the Georgia Composite Medical Board, within the scope their supervising physician delegates. |
| RN | Registered nurses may inject under delegation, and only after a good faith examination has been performed by a prescriber. An RN does not diagnose, prescribe, or independently select a treatment; they carry out tasks within their license and the physician-approved delegation. |
Good faith examination
A good faith examination by a prescriber precedes delegated treatment in Georgia. Registered nurses may administer only after that examination has occurred, and the medical director is responsible for the protocols under which delegation operates.
Ownership and clinic licensing
Georgia applies the corporate practice of medicine doctrine, so an entity offering medical services is owned by licensed physicians or by a physician-owned corporation. Non-physicians run business operations through a management services organisation but do not influence clinical decisions. Structure this with Georgia counsel before opening.
Cold chain into Georgia
Shipments dispatch from our Miami Beach facility under validated temperature monitoring, and delivery into Georgia is scheduled to avoid a weekend hold at the carrier hub.
| Metro | County | Notes |
|---|---|---|
| Atlanta | Fulton | Largest Southeast market outside Florida, with deep aesthetic coverage. |
| Alpharetta | Fulton | Dense north-metro med spa corridor. |
| Savannah | Chatham | Coastal market with dermatology and concierge practices. |
| Augusta | Richmond | Strong clinical and academic medical presence. |
| Columbus | Muscogee | West Georgia market serving the Alabama border. |
| Athens | Clarke | Northeast Georgia hub with a growing aesthetic segment. |
- Georgia orders of fifteen or more cold-chain units ship free nationwide; see the volume program for current thresholds.
- Inspect the temperature indicator on arrival and contact us before use if the shipment reads outside range.
- Storage and handling conditions for each product are stated on its Certificate of Analysis.
Practice types we supply in Georgia
Georgia licensing and verification
Georgia sourcing questions
- Does Georgia HB 1275 cover exosomes?
- No. HB 1275 is a stem cell statute, addressing human stem cells and their retrieval, manufacture, and storage, and its notable feature is allowing a physician assistant or nurse practitioner to perform qualifying therapy under a lawful designation from a physician. Exosomes are acellular and fall outside it. Exosome products are governed federally, and no exosome product is FDA-approved for administration to humans.
- How is Georgia’s law different from Tennessee’s?
- They were enacted eight days apart in May 2026 and went in different directions. Tennessee widened the subject, defining regenerative medicine therapy by supplier documentation and naming exosome-based regenerative products expressly. Georgia widened the operator, letting a PA or nurse practitioner perform qualifying stem cell therapy under a physician’s lawful designation, which no other state authorises. Georgia also declines to limit therapy by condition, where Florida confines its statute to orthopedics, wound care, and pain management.
- What does a Georgia nurse practitioner need in place?
- A written Nurse Protocol Agreement with a delegating physician, defining scope, prescriptive limits, chart review frequency, and communication procedures. It is filed with the Georgia Composite Medical Board before practice begins under it and reviewed at least annually. Georgia is a filing state, so the paperwork precedes the practice rather than documenting it after the fact.
- Can a registered nurse inject in Georgia?
- Under delegation, and only after a good faith examination has been performed by a prescriber. An RN does not diagnose, prescribe, or independently select treatments; they carry out tasks within their license and the physician-approved delegation.
- Does my Georgia clinic need a wholesale distributor license to buy exosomes?
- No. The out-of-state wholesale distributor license under O.C.G.A. 26-4-113 and 26-4-115 is held by the distributor shipping into Georgia, not by the practice buying. Your practice orders against its own professional license and NPI. ExaVeyra handles distribution-side licensing.
- How long does cold-chain shipping take to Georgia?
- Overnight from our Miami Beach facility once prepared, with preparation taking one to two business days. All exosome shipments travel cold-chain with validated temperature monitoring, and deliveries are scheduled to avoid a weekend hold at the carrier hub.
Material available to licensed Georgia practices
Kimera Labs preparations distributed by ExaVeyra, characterised on the certificate of analysis supplied with every lot. Research-grade material for licensed practices; the practitioner determines clinical use.
- Luxir
1 Trillion Microvesicles · 5 Trillion Microvesicles
Available formats: 1.0 mL, 5.0 mL
- Luxir+
3 Trillion Microvesicles · 15 Trillion Microvesicles
Available formats: 1.0 mL, 5.0 mL
- Kiara
3 mg secretome · 15 mg secretome
Available formats: 1.0 mL, 5.0 mL
- Vive
2 Trillion Microvesicles
Available formats: 5.0 mL
Sources
Last reviewed 9 August 2026 by ExaVeyra Sciences editorial team. Every claim above links to a primary source.
- Georgia HB 1275 (2026), bill text (accessed 8 August 2026)
- Georgia Composite Medical Board (accessed 8 August 2026)
- Georgia Board of Pharmacy (accessed 8 August 2026)
- Georgia Drugs and Narcotics Agency (accessed 8 August 2026)
- Georgia Department of Revenue (accessed 8 August 2026)
- FDA Public Safety Notification on Exosome Products (accessed 8 August 2026)
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. There are no FDA-approved exosome products. Biomolecular signaling vesicle products distributed by ExaVeyra Sciences are supplied for topical aesthetic treatments in clinics and for medical, molecular biology, and biochemistry research applications, and are not tissue products as defined by FDA guidelines.
Reference only. Not legal or medical advice.
The content of these guides is provided for general informational purposes only. It does not constitute legal, medical, or regulatory advice, and does not establish that any particular product or practice is compliant. Regulatory requirements vary by state and depend on the circumstances of each practice. Each practitioner should consult their own legal counsel and the applicable state licensing boards before acting on anything stated here.
Read the full disclaimer
ExaVeyra Sciences publishes these guides as a reference for licensed practitioners. They summarize publicly available federal and state requirements as those requirements read on the review date shown above. The content is provided for general informational purposes only and does not constitute legal, medical, or regulatory advice, and it does not establish that any particular product or practice is compliant.
No attorney-client relationship, and no professional or clinical relationship of any kind, is created by accessing these materials. ExaVeyra Sciences is a supplier of research-use materials. It is not a law firm, it is not a regulatory consultant, and it takes no part in any diagnosis, treatment decision, or plan of care. Each practitioner is responsible for retaining their own legal counsel and for determining, with that counsel and the applicable state licensing boards, how the requirements described here apply to the services, staffing, and structure of their own practice.
Statutes, regulations, board rules, and agency positions are subject to amendment, supersession, and reinterpretation. ExaVeyra Sciences makes no representation or warranty as to the accuracy, completeness, timeliness, or applicability of this content to any particular practice. Citations and links to third-party sources are provided for convenience only and do not constitute an endorsement of their content.
The practitioner and the practice are solely responsible for compliance with all applicable licensing, scope of practice, supervision, ownership, facility, recordkeeping, and tax requirements, and for all clinical decisions, including the suitability of any material for a given patient. To the fullest extent permitted by law, ExaVeyra Sciences disclaims all liability for any action taken or not taken in reliance on this content.